BioNTech closes down its former Tübingen competitor CureVac. Does research in Tübingen suffer from this? The state government wants to act quickly.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.